Alyeska Investment Group’s Clarivate CLVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
– Sell
-881,379
Closed -$20.7M – 589
2021
Q4
$20.7M Buy
881,379
+258,110
+41% +$5.98M 0.24% 126
2021
Q3
$13.7M Sell
623,269
-1,172,211
-65% -$28.5M 0.17% 153
2021
Q2
$49.4M Buy
+1,795,480
New +$49.4M 0.57% 41
2020
Q1
– Sell
-764,482
Closed -$12.8M – 385
2019
Q4
$12.8M Buy
764,482
+414,482
+118% +$6.98M 0.17% 155
2019
Q3
$5.91M Buy
+350,000
New +$5.8M 0.09% 209
2019
Q1
– Sell
-250,002
Closed -$2.78M – 387
2018
Q4
$2.39M Buy
+250,002
New +$2.39M 0.03% 277

Other funds holding CLVT

Alyeska Investment Group's CLVT Position: Q1 2022 in Review

Alyeska Investment Group sold out of Clarivate (CLVT) in Q1 2022, closing a stake of 881,379 shares — an estimated $20.7M sold.

Alyeska Investment Group first reported a position in CLVT in Q4 2018 and held it in 6 quarters. The position peaked at $49.4M in Q2 2021. 285 funds tracked by Wall St. Rank hold CLVT as of Q1 2022.

  • Alyeska Investment Group reported no remaining Clarivate position as of Q1 2022 after selling out during the quarter.
  • Alyeska Investment Group sold 881,379 Clarivate shares in Q1 2022, an estimated $20.7M.
  • Alyeska Investment Group first reported a position in Clarivate in Q4 2018 and held it in 6 quarters.
  • Alyeska Investment Group's Clarivate position peaked at $49.4M in Q2 2021.
  • 285 funds tracked by Wall St. Rank held Clarivate as of Q1 2022.

Based on Alyeska Investment Group's 13F filing for Q1 2022, filed 16 May 2022.